Target Name: LOC107984782
NCBI ID: G107984782
Other Name(s): Uncharacterized LOC107984782, transcript variant X1 | LOC107984782 variant X1 | uncharacterized LOC107984782

LOC107984782 Gene: Potential Drug Target Or Biomarker

LOC107984782 (Uncharacterized LOC107984782, transcript variant X1) is a gene that has been identified as a potential drug target or biomarker. The gene is located on chromosome 10q34 and has been shown to be expressed in various tissues and cell types, including human placenta, liver, and pancreas.

The LOC107984782 gene has been identified as a potential drug target due to its involvement in several cellular processes that are relevant to drug development, including inflammation, cell signaling, and metabolism. The gene has been shown to be involved in the production of extracellular matrix (ECM) components, which are important for tissue repair and regeneration.

Additionally, the LOC107984782 gene has been shown to be involved in the production of fibroblasts, which are cells that produce collagen, a protein that is important for tissue structure and integrity. The production of collagen by fibroblasts is often associated with the development of fibromyalgia, a condition characterized by chronic pain and inflammation in connective tissue.

The LOC107984782 gene has also been shown to be involved in the production of lysyl hydroxylase, a enzyme that is involved in the metabolism of lysyl residues, which are important for protein stability and structure. The metabolism of lysyl residues has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its involvement in cellular processes, the LOC107984782 gene has also been shown to be involved in the regulation of gene expression. This is important for the development of new drugs because it allows researchers to understand how the gene is involved in the development and progression of disease.

Overall, the LOC107984782 gene is a promising drug target or biomarker due to its involvement in several cellular processes that are relevant to drug development. Further research is needed to fully understand its role in disease and to develop new treatments.

Protein Name: Uncharacterized LOC107984782

More Common Targets

LOC107984788 | LOC107984793 | LOC107984798 | LOC107984827 | LOC107984867 | LOC107984869 | LOC107984880 | LOC107984901 | LOC107984903 | LOC107984911 | LOC107984913 | LOC107984928 | LOC107984932 | LOC107984934 | LOC107984942 | LOC107984948 | LOC107984965 | LOC107984993 | LOC107985004 | LOC107985038 | LOC107985067 | LOC107985072 | LOC107985085 | LOC107985096 | LOC107985129 | LOC107985157 | LOC107985165 | LOC107985173 | LOC107985174 | LOC107985179 | LOC107985203 | LOC107985204 | LOC107985211 | LOC107985225 | LOC107985239 | LOC107985250 | LOC107985258 | LOC107985270 | LOC107985323 | LOC107985340 | LOC107985360 | LOC107985393 | LOC107985394 | LOC107985434 | LOC107985440 | LOC107985478 | LOC107985479 | LOC107985511 | LOC107985544 | LOC107985590 | LOC107985593 | LOC107985688 | LOC107985690 | LOC107985811 | LOC107985830 | LOC107985854 | LOC107985855 | LOC107985869 | LOC107985870 | LOC107985892 | LOC107985935 | LOC107985940 | LOC107985954 | LOC107985960 | LOC107985969 | LOC107985979 | LOC107985981 | LOC107985984 | LOC107985986 | LOC107985996 | LOC107986003 | LOC107986009 | LOC107986018 | LOC107986022 | LOC107986023 | LOC107986051 | LOC107986056 | LOC107986092 | LOC107986115 | LOC107986139 | LOC107986141 | LOC107986142 | LOC107986146 | LOC107986148 | LOC107986166 | LOC107986178 | LOC107986186 | LOC107986195 | LOC107986203 | LOC107986205 | LOC107986215 | LOC107986223 | LOC107986229 | LOC107986257 | LOC107986272 | LOC107986286 | LOC107986291 | LOC107986297 | LOC107986298 | LOC107986300